
BMS, Nvidia push to build life sciences’ most powerful AI engine
Bristol Myers Squibb is expanding its Nvidia-powered infrastructure with the DGX SuperPOD to create what it calls the most powerful, energy-efficient AI platform in life sciences, enabling hybrid human-AI science to accelerate R&D and improve decision quality across its pipeline; the move extends a multi-year collaboration with Nvidia and aligns with other pharma AI partnerships in the sector.
